SAFINAMIDE

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C17H19FN2O2
Molecular Weight	302.3434
Optical Activity	UNSPECIFIED
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of SAFINAMIDE

Structure Search

SMILES

C[C@H](NCC1=CC=C(OCC2=CC(F)=CC=C2)C=C1)C(N)=O

InChI

InChIKey=NEMGRZFTLSKBAP-LBPRGKRZSA-N

InChI=1S/C17H19FN2O2/c1-12(17(19)21)20-10-13-5-7-16(8-6-13)22-11-14-3-2-4-15(18)9-14/h2-9,12,20H,10-11H2,1H3,(H2,19,21)/t12-/m0/s1

HIDE SMILES / InChI

Molecular Formula	C17H19FN2O2
Molecular Weight	302.3434
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	1 / 1
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Fri Dec 15 16:29:06 UTC 2023` Edited by `admin` on `Fri Dec 15 16:29:06 UTC 2023`
Record UNII	90ENL74SIG
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

SAFINAMIDE

Official Name

English

EMD-1195686

Code

English

safinamide [INN]

Common Name

English

EMD 1195686

Code

English

SAFINAMIDE [MI]

Common Name

English

SAFINAMIDE [USAN]

Common Name

English

Safinamide [WHO-DD]

Common Name

English

Classification Tree Code System Code

WHO-ATC

N04BD03

Created by admin on Fri Dec 15 16:29:06 UTC 2023 , Edited by admin on Fri Dec 15 16:29:06 UTC 2023

NDF-RT

N0000175762

Created by admin on Fri Dec 15 16:29:06 UTC 2023 , Edited by admin on Fri Dec 15 16:29:06 UTC 2023

NCI_THESAURUS

C667

Created by admin on Fri Dec 15 16:29:06 UTC 2023 , Edited by admin on Fri Dec 15 16:29:06 UTC 2023

Code System Code Type Description

MESH

C092797

Created by admin on Fri Dec 15 16:29:06 UTC 2023 , Edited by admin on Fri Dec 15 16:29:06 UTC 2023

PRIMARY

LACTMED

Safinamide

Created by admin on Fri Dec 15 16:29:06 UTC 2023 , Edited by admin on Fri Dec 15 16:29:06 UTC 2023

PRIMARY

DAILYMED

90ENL74SIG

Created by admin on Fri Dec 15 16:29:06 UTC 2023 , Edited by admin on Fri Dec 15 16:29:06 UTC 2023

PRIMARY

CAS

133865-89-1

Created by admin on Fri Dec 15 16:29:06 UTC 2023 , Edited by admin on Fri Dec 15 16:29:06 UTC 2023

PRIMARY

DRUG BANK

DB06654

Created by admin on Fri Dec 15 16:29:06 UTC 2023 , Edited by admin on Fri Dec 15 16:29:06 UTC 2023

PRIMARY

MERCK INDEX

m9720

Created by admin on Fri Dec 15 16:29:06 UTC 2023 , Edited by admin on Fri Dec 15 16:29:06 UTC 2023

PRIMARY

Merck Index

USAN

YY-126

Created by admin on Fri Dec 15 16:29:06 UTC 2023 , Edited by admin on Fri Dec 15 16:29:06 UTC 2023

PRIMARY

FDA UNII

90ENL74SIG

Created by admin on Fri Dec 15 16:29:06 UTC 2023 , Edited by admin on Fri Dec 15 16:29:06 UTC 2023

PRIMARY

PUBCHEM

131682

Created by admin on Fri Dec 15 16:29:06 UTC 2023 , Edited by admin on Fri Dec 15 16:29:06 UTC 2023

PRIMARY

ChEMBL

CHEMBL396778

Created by admin on Fri Dec 15 16:29:06 UTC 2023 , Edited by admin on Fri Dec 15 16:29:06 UTC 2023

PRIMARY

IUPHAR

8291

Created by admin on Fri Dec 15 16:29:06 UTC 2023 , Edited by admin on Fri Dec 15 16:29:06 UTC 2023

PRIMARY

SMS_ID

100000126250

Created by admin on Fri Dec 15 16:29:06 UTC 2023 , Edited by admin on Fri Dec 15 16:29:06 UTC 2023

PRIMARY

NCI_THESAURUS

C76771

Created by admin on Fri Dec 15 16:29:06 UTC 2023 , Edited by admin on Fri Dec 15 16:29:06 UTC 2023

PRIMARY

EVMPD

SUB32946

Created by admin on Fri Dec 15 16:29:06 UTC 2023 , Edited by admin on Fri Dec 15 16:29:06 UTC 2023

PRIMARY

WIKIPEDIA

SAFINAMIDE

Created by admin on Fri Dec 15 16:29:06 UTC 2023 , Edited by admin on Fri Dec 15 16:29:06 UTC 2023

PRIMARY

INN

8013

Created by admin on Fri Dec 15 16:29:06 UTC 2023 , Edited by admin on Fri Dec 15 16:29:06 UTC 2023

PRIMARY

EPA CompTox

DTXSID601010282

Created by admin on Fri Dec 15 16:29:06 UTC 2023 , Edited by admin on Fri Dec 15 16:29:06 UTC 2023

PRIMARY

DRUG CENTRAL

4921

Created by admin on Fri Dec 15 16:29:06 UTC 2023 , Edited by admin on Fri Dec 15 16:29:06 UTC 2023

PRIMARY

RXCUI

1922448

Created by admin on Fri Dec 15 16:29:06 UTC 2023 , Edited by admin on Fri Dec 15 16:29:06 UTC 2023

PRIMARY

Related Record Type Details


					3OV8HVI592

AMINE OXIDASE (FLAVIN-CONTAINING) B

TARGET -> INHIBITOR

Comments:

Human liver mitochondrial fraction, 30-min pre-incubation with substance

Interaction Type:

REVERSIBLE

Qualification:

IC50

Amount:


					3OV8HVI592

AMINE OXIDASE (FLAVIN-CONTAINING) B

TARGET -> INHIBITOR

Interaction Type:

REVERSIBLE

Qualification:

IC50

Amount:


					3OV8HVI592

AMINE OXIDASE (FLAVIN-CONTAINING) B

TARGET -> INHIBITOR

Comments:

Human platelet rich plasma, 30-min pre-incubation with substance

Interaction Type:

REVERSIBLE

Qualification:

IC50

Amount:


					YS90V3DTX0

SAFINAMIDE MESYLATE

SALT/SOLVATE -> PARENT

Amount:


					B5QXZ49C7Y

AMINE OXIDASE (FLAVIN-CONTAINING) A

METABOLIC ENZYME -> SUBSTRATE


					6D53G0FD0Z

PLASMA PROTEIN FRACTION (HUMAN)

BINDER->LIGAND

Interaction Type:

BINDING

Amount:


					3OV8HVI592

AMINE OXIDASE (FLAVIN-CONTAINING) B

METABOLIC ENZYME -> INHIBITOR

Amount:

Related Record Type Details


					WDP88GFK92

NW-1199

METABOLITE INACTIVE -> PARENT

Amount:


					P2678L357C

(S)-2-((4-((3-FLUOROBENZYL)OXY)BENZYL)AMINO)PROPIONIC ACID

METABOLITE INACTIVE -> PARENT


					C2GYP7EAW8

METABOLITE INACTIVE -> PARENT


					24H4YYD325

NW-1717

METABOLITE -> PARENT


					9KQ2XQY9HW

NW-1689

METABOLITE INACTIVE -> PARENT

Amount:

Related Record Type Details


					90ENL74SIG

ACTIVE MOIETY

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Biological Half-life	PHARMACOKINETIC

Volume of Distribution	PHARMACOKINETIC

Tmax	PHARMACOKINETIC